U Of T Researchers Reveal Epstein-Barr Virus Protein Contributes To Cancer

Main Category: Cancer / Oncology
Also Included In: Infectious Diseases / Bacteria / Viruses;  Genetics
Article Date: 07 Oct 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development.

The study findings are published in the journal PLoS Pathogens and describes a novel mechanism by which viral proteins contribute to carcinogenesis.

EBV is a common herpes virus whose latent infection is strongly associated with several types of cancer including NPC, a tumor that is endemic in several parts of the world. With NPC only a few EBV proteins are expressed, including EBNA1. EBNA1 is required for the persistence of the EBV genomes; however, whether or not EBNA1 directly contributes to the development of tumors has not been clear, until now.

The study conducted by Lori Frappier a professor of molecular genetics and her team at the University of Toronto examined PML nuclear bodies and proteins in EBV-positive and EBV-negative NPC cells. Manipulation of EBNA1 levels in each cell type clearly showed that EBNA1 expression induces the loss of PML proteins and PML nuclear bodies through an association of EBNA1 with the PML bodies. PML nuclear bodies are known to have tumor-suppressive effects due to their roles in regulating DNA repair and programmed cell death, and accordingly, EBNA1 was shown to interfere with these processes.

"The findings support an important role for EBNA1 in the development of NPC, in which EBNA1-mediated disruption of PML nuclear bodies promotes the survival of cells with DNA damage," said Frappier. "Since EBNA1 is expressed in all EBV-associated tumors, including B-cell lymphomas and gastric carcinoma, these findings raise the possibility that EBNA1 could play a similar role in the development of these cancers. The cellular effects of EBNA1 in other EBV-induced cancers will require further investigation."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Lori Frappier
University of Toronto